Vaccine Update for Healthcare Providers

Vaccine Resources

CME for pertussis education, learning from Princeton and UCSB meningococcal serogroup B experiences, and revised VIS for adenovirus

CME for pertussis education

The National Foundation for Infectious Diseases (NFID) is offering continuing education credits for review of a series about pertussis. The journal articles resulted from presentations at a working group meeting about pertussis that occurred in March 2013, and include information related to the changing epidemiology of the disease, clinical evaluation of existing vaccines and disease pathogenesis, as well as other topics.

Learn more about NFID programs offering continuing education credits.

Learning from Princeton and UCSB meningococcal serogroup B experiences

NFID recently published a report, “Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses,” to share information related to the recent outbreaks at Princeton and the University of California, Santa Barbara (UCSB). In addition to providing situational summaries, the report describes challenges related to costs and lack of an approved vaccine as well as provides a series of recommendations related to these and other challenges identified during the experiences.

Editor’s Note: The serogroup B meningococcal vaccine used to control the Princeton and UCSB outbreaks, known as Bexero® and manufactured by Novartis, was submitted for licensure to the Food and Drug Administration in June 2014. Similarly, Pfizer’s serogroup B meningococcal vaccine has also been submitted for licensure.

Revised VIS for adenovirus

The U.S. Centers for Disease Control and Prevention (CDC) recently announced the release of an updated version of the Vaccine Information Statement (VIS) for adenovirus. The date on the current version is June 11, 2014.

Make sure your office is distributing the most current VIS for all vaccines by visiting the CDC’s web page.

Finally, did you know that you can view VIS and supporting provider information on your mobile phone? Bookmark the mobile version of the VIS page at http://m.cdc.gov/VIS.

BACK TO TOP

Vaccine exemptions, autism rates and new teen campaign

Vaccine exemptions

The Association of Immunization Managers (AIM) recently released a position statement related to personal belief exemptions (PBE) encouraging states and territories that do not allow PBE to maintain this position and those who do allow them to consider strengthening their position. The AIM position paper was in response to the increased risk of disease in communities that allow PBE.

The Immunization Action Coalition (IAC) has a handout titled “Decision to Not Vaccinate My Child” which includes excerpts from position statements from various national organizations. The form can be signed by the parent and kept on file to indicate the vaccines they refused. Read or print the sheet.

Autism rates

Medscape recently published an interview with Susan L. Hyman, MD, chair of the American Academy of Pediatrics (AAP) Autism subcommittee and a professor of pediatrics at the University of Rochester, discussing “The Reasons behind the Rise in Autism.” Read the interview.

If you do not have a free Medscape account, you will need to register before being able to access the article.

New teen campaign

Parents of Kids with Infectious Diseases (PKIDS) recently launched a new campaign aimed at teens and young adults. Called “Your Choice!” The campaign reminds teens to “take control of your health.”

Materials on the site can be branded by your organization and submitted to local news organizations. FAQ sheets are also available for both teens and parents.

BACK TO TOP

Laminated immunization schedules and CDC recommendations for use of antivirals for influenza

Laminated immunization schedules

The Immunization Action Coalition (IAC) now has available for order useful laminated versions of the 2014 immunization schedules. The full-color schedules include a recommendations table, footnotes, contraindications and precautions. Two versions are available:

Costs vary by quantity ordered. Four or fewer copies are $7.50 each with prices decreasing incrementally to $3.50 per schedule for quantities of 500 to 999. Larger quantities are also available by contacting IAC.

CDC recommendations for use of antivirals for influenza

Following the recent release of the Cochrane report about the benefits of antiviral drugs in treating influenza, the Centers for Disease Control and Prevention (CDC) re-emphasized their recommendations related to the use of antivirals for treating influenza. Specifically,

The CDC has a useful document that includes a summary table outlining recommendations related to this subject. Several additional resources are compiled on the CDC’s related Web page.

CDC news and vaccine-related Tedx Talk

BACK TO TOP

CDC news

The Centers for Disease Control and Prevention (CDC) announced the introduction of a new Twitter account, @CDCizlearn. They plan to post information about immunization-related education, training and practice resources for healthcare providers and others interested in administration and delivery of vaccines. Questions about the Twitter account can be emailed to izlearn@cdc.gov.

The CDC has also announced removal of the multi-vaccine VIS (11/16/12), so that it can be updated. In the interim, rather than using that sheet, provide parents with the individual VISs. This information is posted on the CDC’s VIS announcements page.

Vaccine-related Tedx Talk

The Immunization Partnership in Texas recently launched a new website, immunizeUSA.org. In addition to education and advocacy sections, the site includes a wonderful Tedx Talk video by Anna Dragsbaek, President and CEO of The Immunization Partnership. The Tedx Talk video, titled “The Scream That Should Be Heard Around the World,” is also available on YouTube.

BACK TO TOP

CDC VIS and training modules updates

VIS Updates

The Centers for Disease Control and Prevention (CDC) recently made updates to the following Vaccine Information Statements (VIS):

Be sure you are using the most up-to-date VIS by checking the CDC’s summary page.

Get other languages from the IAC’s library of VIS.

Make sure your office is using VIS correctly.

CDC training modules updates

The CDC recently updated two modules in the “You Call the Shots” training course:

The “You Call the Shots” modules are free, Web-based training modules intended for nurses, medical assistants, pharmacists and other health professionals who administer immunizations. The modules are also useful for students in fields of study that will eventually administer vaccines. Continuing education credits are also available.

BACK TO TOP

Cervivor interview series; HPV vaccine recall

Cervivor interview series

Cervivor is a new series launched by Tamika & Friends, a group of cervical cancer survivors. In this online series Tamika interviews other cervical cancer survivors as they share their stories of hope and survival. The group is having a three-day survivor retreat during January 2014.

HPV vaccine recall

Merck voluntarily recalled one lot of Gardasil® because a small number of vials might have been contaminated with glass introduced by breakage during the production process:

For more information, consult the CDC’s related media statement.

BACK TO TOP

  • Print
  • Share

Contact Us

We welcome your input. Please contact us with story ideas, questions or other comments:

Vaccine Educational Materials